Beautiful young woman relaxing at park during autumn season with closed eyes. Happy free natural girl breathing deeply in park with foliage in background. Pretty woman expressing freedom outdoor.

Novartis Pharms. Corp. v. Alembic Pharms. Ltd. – Entresto® (Sacubitril/Valsartan)

Start
Case Name: Novartis Pharms. Corp. v. Alembic Pharms. Ltd., Civ. No. 22-1395-RGA, 2023 WL 6387975 (D. Del. Sept. 29, 2023) (Andrews, J.). Drug Product and Patent(s)-in-Suit: Entresto® (sacubitril/valsartan); U.S. Patent No. 11,096,918 (“the ’918 patent”)….
By: Robins Kaplan LLP
Previous Story

Trending in Telehealth: November 8 – 14, 2023

Next Story

[Webinar] Tech-Backed Terror: Navigating the Intersection of AI, Cryptocurrency, Money Laundering, and “Proliferation Financing” – December 1st, 1:00 pm – 2:00 pm ET